Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death

Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors

(2018) Nan-nan Wang et al.   EXPERIMENTAL CELL RESEARCH

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC

(2017) Lauren MacDonagh et al.   Oncotarget

Clinical features and prognostic factors in patients with head and neck cancer: Results from a multicentric study

(2015) Emanuele Leoncini et al.   Cancer Epidemiology

Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer

(2015) Jennifer L. Allensworth et al.   Molecular Oncology

Copper Signaling Axis as a Target for Prostate Cancer Therapeutics

(2014) R. Safi et al.   CANCER RESEARCH

Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition

(2014) Jie Zha et al.   Journal of Translational Medicine

Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects

(2012) Robert P. Takes et al.   ORAL ONCOLOGY

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

(2011) N C Yip et al.   BRITISH JOURNAL OF CANCER

Mining for therapeutic gold

(2011) Francis S. Collins   NATURE REVIEWS DRUG DISCOVERY

Direct Measurement of Free Copper in Serum or Plasma Ultrafiltrate

(2009) Gwendolyn A. McMillin et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

(2009) K. Iljin et al.   CLINICAL CANCER RESEARCH